Monograph
D11AH02 - Pimecrolimus |
Propably not porphyrinogenic |
PNP |
Rationale
Substrate for CYP 3A4 but due to the high skin selectivity the systemic exposure and the hepatic load are insignificant.
Chemical description
Lipohilic ascomycinmacrolactam derivative with dermal antiinflammatory action Used in atopic dermatitis applied to the skin as creme 1%. Very high skin selectively, blood concentration less than 1 ng/mL. No metabolism observed.
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
© NAPOS 2024